high risk prostate cancer and mhspc | with axel merseburger
Published 5 months ago • 596 plays • Length 26:49Download video MP4
Download video MP3
Similar videos
-
4:39
clinical insights into prostate cancer trial data | axel merseburger
-
4:40
axel merseburger, esmo 2019 - advances in metastatic hormone-sensitive prostate cancer
-
3:24
expert highlights from asco gu 2020 | axel merseburger
-
18:02
hormone therapy as a primary treatment | #markscholzmd #alexscholz #pcri
-
17:32
how does #prostatecancer spread to the bones? | spot & injectable radiation | #markscholzmd
-
13:43
#prostatecancer diagnosis over 80 years old | #markscholzmd #alexscholz | #pcri
-
1:44
introducing axel merseburger
-
12:46
debulking & metastatic #prostatecancer | #markscholzmd #alexscholz #pcri
-
10:49
imrt vs. sbrt & reducing radiation toxicity | #markscholzmd #alexscholz #pcri
-
2:18
prostate cancer picks from #esmo21 from dr. axel merseburger
-
2:36
advanced prostate cancer treatment – if, when and what?
-
5:54
high-risk prostate cancer: benefit to adding 2nd generation hormone therapy or chemo? | pcri
-
5:32
understanding treatment for high-risk prostate cancer | prostate cancer staging guide
-
5:08
is seminal vesicle invasion considered metastatic disease? | mark scholz, md | pcri
-
19:21
predicting survival of men with prostate cancer after rp
-
9:32
high risk prostate cancer: surgery vs. radiation | genomic tests | mark scholz, md | pcri
-
3:30
high-risk prostate cancer clinic
-
2:37
investigating the clinical and molecular biology of high-risk prostate cancer
-
6:41
prostate cancer myths | ask a prostate cancer expert, mark scholz, md
-
3:40
immune health and prostate cancer | ask a prostate expert, mark scholz, md